Visualizing the Knowledge domain of nanoparticle drug delivery technologies: A scientometric review

Applied Sciences (Switzerland)

Volumn 6, Issue 1, 2016, Pages

  Lee, Yen Chun ^a   Chen, Chaomei ^b   Tsai, Xing Tzu ^a  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b Drexel University   (United States)

Author keywords

Drug delivery; Knowledge domain; Nanoparticle; Scientometrics

Indexed keywords

EID: 84973665039     PISSN: None     EISSN: 20763417     Source Type: Journal    
DOI: 10.3390/app6010011     Document Type: Review

References (73)

1. Bhowmik, D.; Duraivel, S.; Kumar, K.S. Recent trends in challenges and opportunities in transdermal drug delivery system. Pharma Innov. 2012, 1, 9-23.
2. NirvedV, U.; Lokesh, V.; Prasad, M.G.; Joshi, H.M. Formulation and evaluation of ethosomes of sesbania grandiflora linn. Seeds. Nov. Sci. Int. J. Pharm. Sci. 2012, 1, 274-275.
3. Shi, J.; Votruba, A.R.; Farokhzad, O.C.; Langer, R. Nanotechnology in drug delivery and tissue engineering: From discovery to applications. Nano Lett. 2010, 10, 3223-3230.
4. Chen, C. The Citespace Manual. Available online: http://cluster.ischool.drexel.edu/~cchen/citespace/Cite SpaceManual.pdf (accessed on 2 May 2015).
5. Wenger, E.; McDermott, R.; Snyder, W.M. Cultivating Communities of Practice: A Guide to Managing Knowledge; Harvard Business Press: Boston, MA, USA, 2002; pp. 202-258.
6. Hu, C.; Racherla, P. Visual representation of knowledge networks: A social network analysis of hospitality research domain. Int. J. Hosp. Manag. 2008, 27, 302-312.
7. Chen, C. The Dynamics of Scientific Knowledge. In Mapping Scientific Frontiers; Springer: London, UK, 2013; pp. 1-46.
8. De Jong, W.H.; Borm, P.J. Drug delivery and nanoparticles: Applications and hazards. Int. J. Nanomed. 2008, 3, 133-149.
9. Chen, C.; Dubin, R.; Kim, M.C. Emerging trends and new developments in regenerative medicine: A scientometric update (2000-2014). Expert Opin. Biol. Ther. 2014, 14, 1295-1317.
10. Chen, C.; Dubin, R.; Kim, M.C. Orphan drugs and rare diseases: A scientometric review (2000-2014). Expert Opin. Orphan Drugs 2014, 2, 709-724.
11. Chen, C. Citespace II: Detecting and visualizing emerging trends and transient patterns in scientific literature. J. Am. Soc. Inf. Sci. Technol. 2006, 57, 359-377.
12. Chen, C. The Structure and Dynamics of Scientific Knowledge. In Mapping Scientific Frontiers; Springer: London, UK, 2013; pp. 163-199.
13. Wei, F.; Grubesic, T.H.; Bishop, B.W. Exploring the GIS knowledge domain using Citespace. Prof. Geographer 2015, 67, 1-11.
14. Yu, P.; van de Sompel, H. Networks of scientific papers. Science 1965, 169, 510-515.
15. Peer, D.; Karp, J.M.; Hong, S.; Farokhzad, O.C.; Margalit, R.; Langer, R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2, 751-760.
16. Gupta, A.K.; Gupta, M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26, 3995-4021.
17. Liong, M.; Lu, J.; Kovochich, M.; Xia, T.; Ruehm, S.G.; Nel, A.E.; Tamanoi, F.; Zink, J.I. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2008, 2, 889-896.
18. Neuberger, T.; Schöpf, B.; Hofmann, H.; Hofmann, M.; von Rechenberg, B. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. J. Magn. Magn. Mater. 2005, 293, 483-496.
19. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor vascular permeability and the epr effect in macromolecular therapeutics: A review. J. Controll. Release 2000, 65, 271-284.
20. Aswathy, R.G.; Yoshida, Y.; Maekawa, T.; Kumar, D.S. Near-infrared quantum dots for deep tissue imaging. Anal. Bioanal. Chem. 2010, 397, 1417-1435.
21. Alkilany, A.M.; Murphy, C.J. Toxicity and cellular uptake of gold nanoparticles: What we have learned so far? J. Nanopart. Res. 2010, 12, 2313-2333.
22. Chithrani, D.B. Intracellular uptake, transport, and processing of gold nanostructures. Mol. Membr. Biol. 2010, 27, 299-311.
23. Hao, R.; Xing, R.; Xu, Z.; Hou, Y.; Gao, S.; Sun, S. Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles. Adv. Mater. 2010, 22, 2729-2742.
24. Veiseh, O.; Gunn, J.W.; Zhang, M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv. Drug Deliv. Rev. 2010, 62, 284-304.
25. Faraji, M.; Yamini, Y.; Rezaee, M. Magnetic nanoparticles: Synthesis, stabilization, functionalization, characterization, and applications. J. Iran. Chem. Soc. 2010, 7, 1-37.
26. Ratzinger, G.; Fillafer, C.; Kerleta, V.; Wirth, M.; Gabor, F. The role of surface functionalization in the design of plga micro-and nanoparticles. Crit. Rev. Ther. Drug 2010, 27, 1-83.
27. Roger, E.; Lagarce, F.; Garcion, E.; Benoit, J.-P. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. Nanomedicine 2010, 5, 287-306.
28. Patel, N.R.; Damann, K.; Leonardi, C.; Sabliov, C.M. Itraconazole-loaded poly (lactic-co-glycolic) acid nanoparticles for improved antifungal activity. Nanomedicine 2010, 5, 1037-1050.
29. Rosenholm, J.M.; Sahlgren, C.; Lindén, M. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles-Opportunities & challenges. Nanoscale 2010, 2, 1870-1883.
30. Slowing, I.I.; Vivero-Escoto, J.L.; Trewyn, B.G.; Lin, V.S.-Y. Mesoporous silica nanoparticles: Structural design and applications. J. Mater. Chem. 2010, 20, 7924-7937.
31. Oerlemans, C.; Bult,W.; Bos, M.; Storm, G.; Nijsen, J.F.W.; Hennink,W.E. Polymeric micelles in anticancer therapy: Targeting, imaging and triggered release. Pharm. Res. 2010, 27, 2569-2589.
32. Kedar, U.; Phutane, P.; Shidhaye, S.; Kadam, V. Advances in polymeric micelles for drug delivery and tumor targeting. Nanomed. Nanotech. Biol. Med. 2010, 6, 714-729.
33. Li, C.; Lin, J. Rare earth fluoride nano-/microcrystals: Synthesis, surface modification and application. J. Mater. Chem. 2010, 20, 6831-6847.
34. Chen, F.; Zhang, S.; Bu,W.; Liu, X.; Chen, Y.; He, Q.; Zhu, M.; Zhang, L.; Zhou, L.; Peng,W. A "neck-formation" strategy for an antiquenching magnetic/upconversion fluorescent bimodal cancer probe. Chem. Eur. J. 2010, 16, 11254-11260.
35. Liu, Q.; Sun, Y.; Yang, T.; Feng,W.; Li, C.; Li, F. Sub-10 nm hexagonal lanthanide-doped NaLuF4 upconversion nanocrystals for sensitive bioimaging in vivo. J. Am. Chem. Soc. 2011, 133, 17122-17125.
36. Stöber, W.; Fink, A.; Bohn, E. Controlled growth of monodisperse silica spheres in the micron size range. J. Colloid Interface Sci. 1968, 26, 62-69.
37. Yoon, T.J.; Kim, J.S.; Kim, B.G.; Yu, K.N.; Cho, M.H.; Lee, J.K. Multifunctional nanoparticles possessing a "magnetic motor effect" for drug or gene delivery. Angew. Chem. Int. Ed. 2005, 117, 1092-1095.
38. Giri, S.; Trewyn, B.G.; Stellmaker, M.P.; Lin, V.S.Y. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew. Chem. Int. Ed. 2005, 44, 5038-5044.
39. Gao, X.; Cui, Y.; Levenson, R.M.; Chung, L.W.; Nie, S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotech. 2004, 22, 969-976.
40. Tang, F.; Li, L.; Chen, D. Mesoporous silica nanoparticles: Synthesis, biocompatibility and drug delivery. Adv. Mater. 2012, 24, 1504-1534.
41. Yang, P.; Gai, S.; Lin, J. Functionalized mesoporous silica materials for controlled drug delivery. Chem. Soc. Rev. 2012, 41, 3679-3698.
42. Li, Z.; Barnes, J.C.; Bosoy, A.; Stoddart, J.F.; Zink, J.I. Mesoporous silica nanoparticles in biomedical applications. Chem. Soc. Rev. 2012, 41, 2590-2605.
43. Liong, M.; Angelos, S.; Choi, E.; Patel, K.; Stoddart, J.F.; Zink, J.I. Mesostructured multifunctional nanoparticles for imaging and drug delivery. J. Mater. Chem. 2009, 19, 6251-6257.
44. Trewyn, B.G.; Giri, S.; Slowing, I.I.; Lin, V.S.-Y. Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems. Chem. Commun. 2007.
45. Tian, G.; Gu, Z.; Zhou, L.; Yin,W.; Liu, X.; Yan, L.; Jin, S.; Ren,W.; Xing, G.; Li, S. Mn2+ dopant-controlled synthesis of NaYF4: Yb/Er upconversion nanoparticles for in vivo imaging and drug delivery. Adv. Mater. 2012, 24, 1226-1231.
46. Zhou, J.; Liu, Z.; Li, F. Upconversion nanophosphors for small-animal imaging. Chem. Soc. Rev. 2012, 41, 1323-1349.
47. Haase, M.; Schäfer, H. Upconverting nanoparticles. Angew. Chem. Int. Ed. 2011, 50, 5808-5829.
48. Wang, F.; Liu, X. Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals. Chem. Soc. Rev. 2009, 38, 976-989.
49. Wang, F.; Han, Y.; Lim, C.S.; Lu, Y.; Wang, J.; Xu, J.; Chen, H.; Zhang, C.; Hong, M.; Liu, X. Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nature 2010, 463, 1061-1065.
50. Chaw, C.-S.; Chooi, K.-W.; Liu, X.-M.; Tan, C.-W.; Wang, L.; Yang, Y.-Y. Thermally responsive core-shell nanoparticles self-assembled from cholesteryl end-capped and grafted polyacrylamides: Drug incorporation and in vitro release. Biomaterials 2004, 25, 4297-4308.
51. Feng, S.-S.; Mu, L.;Win, K.Y.; Huang, G. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Curr. Med. Chem. 2004, 11, 413-424.
52. Anderson, S.A.; Rader, R.K.; Westlin, W.F.; Null, C.; Jackson, D.; Lanza, G.M.; Wickline, S.A.; Kotyk, J.J. Magnetic resonance contrast enhancement of neovasculature withαvβ3-targeted nanoparticles. Magn. Reson. Med. 2000, 44, 433-439.
53. Liu, X.-M.; Yang, Y.-Y.; Leong, K.W. Thermally responsive polymeric micellar nanoparticles self-assembled from cholesteryl end-capped random poly (N-isopropylacrylamide-co-N, N-dimethylacrylamide): Synthesis, temperature-sensitivity, and morphologies. J. Colloid Interface Sci. 2003, 266, 295-303.
54. Little, S.R.; Lynn, D.M.; Ge, Q.; Anderson, D.G.; Puram, S.V.; Chen, J.; Eisen, H.N.; Langer, R. Poly-amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. Proc. Natl. Acad. Sci. USA 2004, 101, 9534-9539.
55. Jain, T.K.; Richey, J.; Strand, M.; Leslie-Pelecky, D.L.; Flask, C.A.; Labhasetwar, V. Magnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imaging. Biomaterials 2008, 29, 4012-4021.
56. Winter, P.M.; Morawski, A.M.; Caruthers, S.D.; Fuhrhop, R.W.; Zhang, H.; Williams, T.A.; Allen, J.S.; Lacy, E.K.; Robertson, J.D.; Lanza, G.M. Molecular imaging of angiogenesis in early-stage atherosclerosis with v3-integrin-targeted nanoparticles. Circulation 2003, 108, 2270-2274.
57. McCarthy, J.R.; Weissleder, R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv. Drug Deliv. Rev. 2008, 60, 1241-1251.
58. Hood, J.D.; Bednarski, M.; Frausto, R.; Guccione, S.; Reisfeld, R.A.; Xiang, R.; Cheresh, D.A. Tumor regression by targeted gene delivery to the neovasculature. Science 2002, 296, 2404-2407.
59. Lu, J.; Liong, M.; Li, Z.; Zink, J.I.; Tamanoi, F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica anoparticles for cancer therapy in animals. Small 2010, 6, 1794-1805.
60. Ashley, C.E.; Carnes, E.C.; Phillips, G.K.; Padilla, D.; Durfee, P.N.; Brown, P.A.; Hanna, T.N.; Liu, J.; Phillips, B.; Carter, M.B. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat. Mater. 2011, 10, 389-397.
61. Vivero-Escoto, J.L.; Slowing, I.I.; Trewyn, B.G.; Lin, V.S.Y. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 2010, 6, 1952-1967.
62. Meng, H.; Liong, M.; Xia, T.; Li, Z.; Ji, Z.; Zink, J.I.; Nel, A.E. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and p-glycoprotein sirna to overcome drug resistance in a cancer cell line. ACS Nano 2010, 4, 4539-4550.
63. Pan, L.; He, Q.; Liu, J.; Chen, Y.; Ma, M.; Zhang, L.; Shi, J. Nuclear-targeted drug delivery of tat peptide-conjugated monodisperse mesoporous silica nanoparticles. J. Am. Chem. Soc. 2012, 134, 5722-5725.
64. Du, J.-Z.; Du, X.-J.; Mao, C.-Q.; Wang, J. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. J. Am. Chem. Soc. 2011, 133, 17560-17563.
65. Liu, J.; Qiao, S.Z.; Chen, J.S.; Lou, X.W.D.; Xing, X.; Lu, G.Q.M. Yolk/shell nanoparticles: New platforms for nanoreactors, drug delivery and lithium-ion batteries. Chem. Commun. 2011, 47, 12578-12591.
66. Albanese, A.; Tang, P.S.; Chan,W.C. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng. 2012, 14, 1-16.
67. Zhang, Z.; Wang, L.; Wang, J.; Jiang, X.; Li, X.; Hu, Z.; Ji, Y.; Wu, X.; Chen, C. Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment. Adv. Mater. 2012, 24, 1418-1423.
68. Wang, A.Z.; Langer, R.; Farokhzad, O.C. Nanoparticle delivery of cancer drugs. Annu. Rev. Med. 2012, 63, 185-198.
69. Wang, F.; Wang, Y.-C.; Dou, S.; Xiong, M.-H.; Sun, T.-M.; Wang, J. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. Acs Nano 2011, 5, 3679-3692.
70. Luo, Z.; Cai, K.; Hu, Y.; Zhao, L.; Liu, P.; Duan, L.; Yang, W. Mesoporous silica nanoparticles end-capped with collagen: Redox-responsive nanoreservoirs for targeted drug delivery. Angew. Chem. Int. Ed. 2011, 50, 640-643.
71. Auzel, F. Upconversion and anti-stokes processes with f and d ions in solids. Chem. Rev. 2004, 104, 139-174.
72. He, Q.; Shi, J. Mesoporous silica nanoparticle based nano drug delivery systems: Synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J. Mater. Chem. 2011, 21, 5845-5855.
73. Thomas, C.R.; Ferris, D.P.; Lee, J.-H.; Choi, E.; Cho, M.H.; Kim, E.S.; Stoddart, J.F.; Shin, J.-S.; Cheon, J.; Zink, J.I. Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. J. Am. Chem. Soc. 2010, 132, 10623-10625.